Apollomics Inc - Class A (APLM) Stock Price

23.48 ▲ +0.08 (+0.34%)
Open: 23.48 Vol: 1.31K Day's range: 23.48 - 23.48 Sep 24, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
APLM Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 23.08▲ 22.90▲ 22.90▲ 23.59▼ 24.84▼
MA10 22.59▲ 22.73▲ 22.73▲ 23.30▲ 22.43▲
MA20 22.67▲ 23.19▲ 23.23▲ 24.80▼ 19.56▲
MA50 23.69▲ 23.05▲ 22.22▲ 21.80▲ 18.48▲
MA100 21.84▲ 20.60▲ 20.46▲ 18.98▲ 13.22▲
MA200 20.10▲ 18.87▲ 18.99▲ 18.49▲ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD 0.187▲ -0.005▼ -0.078▼ -0.364▼ 0.483▲
RSI 59.850▲ 53.815▲ 54.199▲ 50.171▲ 59.269▲
STOCH 70.387     59.630     57.749     48.273     74.339    
WILL %R 0.000▲ 0.000▲ -13.134▲ -63.882     -34.162    
CCI 165.589▲ 185.712▲ 139.085▲ -32.178     46.858    
Latest Filters Detected On APLM
RSI $APLM RSI(14) Crossed Above 50 Set Alert
CDL $APLM Doji Star Candlestick Pattern Detected Set Alert
CDL $APLM Doji Candlestick Pattern Detected Set Alert
Apollomics Inc - Class A News
Apollomics Regains Full Compliance with Nasdaq Listing Requirements
Monday, July 13, 2026 05:00 AM
FOSTER CITY, Calif., July 13, 2026 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) ("Apollomics" or the "Company"), a late-stage clinical biopharmaceutical company developing multiple oncology drug ...
Apollomics Receives Nasdaq Deficiency Notice Regarding Minimum Market Value Requirement and Updates Rights for Vebreltinib (APL-101) in Asia
Wednesday, June 24, 2026 09:15 PM
FOSTER CITY, Calif., June 24, 2026 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a late-stage clinical biopharmaceutical company developing multiple oncology drug ...
Apollomics (APLM) Announces Top-line Results for Phase 3 Bridging Trial of Uproleselan in China
Friday, December 20, 2024 12:01 AM
Apollomics Inc. (Nasdaq: APLM) announced today the results from its Phase 3 bridging trial of uproleselan in China in patients with relapsed or refractory acute myeloid leukemia. The trial did not ...
APLM historical stock data
date open high low close volume
24/09/26 23.48 23.48 23.48 23.48 1,308
23/09/26 22.76 24.10 21.8838 23.40 24,955
22/09/26 25.00 25.00 22.23 23.72 3,228
21/09/26 23.96 25.00 23.91 23.91 2,839
18/09/26 22.50 24.77 22.50 23.42 6,727
17/09/26 23.00 24.9999 22.525 22.525 2,981
16/09/26 22.615 22.83 21.59 22.105 10,339
15/09/26 23.89 24.02 22.90 24.02 6,251
14/09/26 23.18 23.18 23.18 23.18 503
11/09/26 24.03 24.03 21.21 23.205 5,851
Quote Details
52wk Low:5.20
52wk High:36.525
Vol:1.31K
Avg Vol(3m):463.6K
1Y Chng:+27.38%
1M Chng:+37.63%
Add to Watch List
More Information
Index US Composite
Market Cap. 68.21M